Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × Inhalation × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Respiratory Aspiration 2 Neurofibromatosis 1 1 Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

AZD 6244 11 trametinib 2 Lasers, Solid-State 2 Deoxycholic Acid 2 thymoglobulin 1 talimogene laherparepvec 1 omipalisib 1 mirdametinib 1 fludarabine 1 dabrafenib 1 cabozantinib 1 binimetinib 1 Waiting Lists 1 Vincristine 1 Specimen Handling 1 Rituximab 1 Polidocanol 1 Photochemotherapy 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lovastatin 1 Liquid Biopsy 1 Levetiracetam 1 Lasers 1 Inhalation 1 Dosage Forms 1 Cyclophosphamide 1 Curcumin 1 Carboplatin 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04481035 2025-07-31

NF1NAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed

5 enrolled 10 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡